CN1049586C - Dressing medicine for treating hyperosteogeny and the prepn. method - Google Patents
Dressing medicine for treating hyperosteogeny and the prepn. method Download PDFInfo
- Publication number
- CN1049586C CN1049586C CN94103521A CN94103521A CN1049586C CN 1049586 C CN1049586 C CN 1049586C CN 94103521 A CN94103521 A CN 94103521A CN 94103521 A CN94103521 A CN 94103521A CN 1049586 C CN1049586 C CN 1049586C
- Authority
- CN
- China
- Prior art keywords
- rhizoma
- radix
- colophonium
- medicine
- camphora
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a traditional Chinese medicine for treating hyperosteogeny, and a preparation method for the medicine. The medicine is an external preparation prepared by that rhizoma drynariae, raw frankincense, raw myrrh, raw sichuan axonite root, raw wild aconite, raw arisaema, notopterygium root, pubescent angelica root, Chinese honeylocust abnormal fruit, pricklyash peel, etc. are mixed, pulverized, sieved and packaged by using cloth. The medicine integrates kidney tonifying, bone strengthening, blood circulation activation for removing blood stasis, detumescence, pain alleviation, and channel warming for dispelling cold, treats both manifestation and root cause of hyperosteogeny, has a definite therapeutic effect on hyperosteogeny, and has the advantages of little irritability, high permeability, good ventilation property, no toxic or side effect, and total effective rate of 95.40%.
Description
The present invention relates to a kind of Chinese medicine for the treatment of bone matrix hyperplasia, the particularly a kind of externally dressing of hyperosteogeny and its preparation method of being used for.
The functional disorder that bone matrix hyperplasia causes, be in, old people's common frdquently encountered disease, clinically see so that cervical vertebra, lumbar vertebra, knee joint and calcaneus osseous part bony spur more especially.Owing to symptoms such as various dysfunctions appear in patient's local pain, swelling, numbness, gently then influence live and work, heavy then can disability, having a strong impact on patient's physical and mental health.The medicament categories that is used at present treating bone matrix hyperplasia clinically is a lot, and its treatment mechanism be blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain mostly, just plays for hyperosteogeny and suppresses and the pain that disappears acting on, and can not fundamentally cure hyperosteogeny.It is several to be divided into pill, capsule, electuary, decoction, medicated wine, plaster and liniment etc. again according to pharmaceutical dosage form, wherein the deficiency of pill such as anti-hyperosteogeny pill, capsule such as JINGFUKANG, electuary such as JINGTONGLING existence is that medicine is reached the affected part by whole body absorption, difficulty, needs dosage very big; Though liquor preparations such as bone agent pain-relieving liquid can reach the affected part rapidly, because the ethanol stimulating intestine and stomach, making has digestive tract disease and use that can not alcoholic patient to be restricted; Decoction formulation has the trouble of long-term decoction, and the property of medicine of some activating blood circulation and dissipating blood stasis medicines is galloping brave in the decoction, physical weakness and have the patient of chronic medical history to take; In the medicine for external use traditional medications such as hard plaster such as GUCITING, rubber plaster such as rheumatalgia relieving plaster exist breathability poor, cause skin allergy easily, should not paste for a long time and deficiency such as use; And outer liniments such as GUYOULING, GUZHINING are because the medicine highly volatile, and local action is lasting and curative effect is not really remarkable.
The object of the present invention is to provide a kind for the treatment of both the principal and secondary aspects of a disease, can be absorbed by the affected part fully fast by messenger drug, evident in efficacy, and make dressing medicine for treating hyperosteogeny simple, safe and convenient to use and method for making thereof.
Dressing medicine for treating hyperosteogeny of the present invention includes Rhizoma Drynariae, Olibanum, Myrrha, Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma Arisaematis, Rhizoma Pinelliae, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Semen Sinapis Albae, Fructus Gleditsiae Abnormalis, Flos Carthami, Lignum Sappan, Herba Asari, Herba speranskiae tuberculatae, Camphora, Borneolum Syntheticum and Colophonium, and its concrete percentage by weight is:
Rhizoma Drynariae 3-6% Olibanum 3-8%
Myrrha 3-8% Radix Aconiti 2-6%
Radix Aconiti Kusnezoffii 2-6% Rhizoma Arisaematis 4-8%
Rhizoma Pinelliae 4-8% Rhizoma Et Radix Notopterygii 2-8%
Radix Angelicae Pubescentis 2-8% Semen Sinapis Albae 2-5%
Fructus Gleditsiae Abnormalis 2-5% Flos Carthami 2-5%
Lignum Sappan 2-5% Herba Asari 1-4%
Pericarpium Zanthoxyli 1-4% Herba speranskiae tuberculatae 2-6%
Camphora 5-15% Borneolum Syntheticum 1-2%
Colophonium 2-5%
According to seeing so that cervical vertebra, waist, knee joint and four position hyperosteogenys of calcaneus more clinically, at different therapentic parts, increased a few flavor Chinese medicines such as living Radix Puerariae, Herba Epimedii, Radix Achyranthis Bidentatae, Radix Et Rhizoma Rhei again respectively, specifically:
Increase during the treatment hyperosteogeny of cervical vertebra and give birth to Radix Puerariae, addition is 4-8%;
Increase Herba Epimedii during the treatment lumbar vertebra hyperosteogeny, addition is 4-8%;
Increase Radix Achyranthis Bidentatae during the treatment knee joint hyperosteogeny, addition is 4-8%;
Treatment calcaneus portion increases Radix Et Rhizoma Rhei during hyperosteogeny, and addition is 4-8%.
The processing technology of dressing medicine for treating hyperosteogeny of the present invention is: earlier with Camphora, Borneolum Syntheticum and Colophonium pulverize separately, and cross the 100-140 mesh sieve respectively.After according to dosage ratio requirement is mixed with all the other Chinese medicines of respectively distinguishing the flavor of according to different therapentic parts, pulverize and cross the 60-100 mesh sieve together, add Camphora, Borneolum Syntheticum and Colophonium and the abundant mix homogeneously of aequum in the screening, get doses and pack with cloth, the external plastic bag sealing is made.
Hyperosteogeny is the sclerotin degenerative change, and motherland's medical science is thought: " kidney governing bones is given birth to marrow." marrow of suffering from a deficiency of the kidney then can not expire, also can not nourishing bone.The crucial pathogenesis of hyperosteogeny is: insufficiency of kidney-YANG is this, and blood stasis, the expectorant stasis of blood, wind, cold, arthralgia chiefly caused by damp pathogen to marking.So giving consideration to both the incidental and fundamental work as in treatment, both invigorating the kidney and strengthening the bones, again blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, eleminating phlegm and freeing channels, by except that rheumatism, dispelling cold by warming the meridian.Dressing medicine for treating hyperosteogeny is with Rhizoma Drynariae, Herba Epimedii invigorating the kidney and strengthening the bones; Myrrha, Olibanum, Flos Carthami, Lignum Sappan promoting blood circulation to remove obstruction in the collateral, stasis-dispelling and pain-killing, promotion local blood circulation; Rhizoma Pinelliae, Rhizoma Arisaematis, Semen Sinapis Albae are by expectorant collateral dredging, detumescence relieving accumulation of pathogens; Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Herba speranskiae tuberculatae dispelling cold by warming the meridian, treatment of arthritis and promoting collateral and channels are to remove the limbs arthralgia pain; Add Colophonium end dampness wind-expelling pain-stopping in addition; Fructus Gleditsiae Abnormalis is not only subsided a swelling and is invigorated blood circulation, and in transdermal is sensible, priming goes into; Herba Asari, the Pericarpium Zanthoxyli acrid in the mouth is warm in nature, abnormal smells from the patient is male strong, and expulsion wind, cold, wet power are outstanding especially, and share with Radix Aconiti, Radix Aconiti Kusnezoffii can promoting the flow of QI in the collateral by warming the meridian, remove heavy cold obstinate disease in the cold-damp inside and outside the exterior and the interior, the body of dispelling; Compatibility with Borneolum Syntheticum, Camphora detumescence, heat radiation, pain relieving, anticorrosion, causing resuscitation with aromatic drugs is logical closes, and can promote the osmotic absorption of medicine, through sick place.More than all medicine compatibilities, can destroy the internal milieu of growth bony spur, suppress the growth of bony spur, improve local blood circulation rapidly, eliminate symptom.
Compare with the described various treatment hyperosteogeny medicines of background technology, the present invention has the advantage of following several respects:
1, the present invention adopts pure natural medical, conscientiously studies the performance and the function of each flavor medical material, through repetition test, screening, and tight compatibility, and select out best proportional quantity.On the Therapeutic Principle, melt invigorating the kidney and strengthening the bones, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, eleminating phlegm and freeing channels, pursue and remove rheumatism, dispelling cold by warming the meridian in a stove, giving consideration to both the incidental and fundamental, for bone matrix hyperplasia determined curative effect, effect rapidly.Not only can eliminate the limbs pain, the numbness that stimulate the local organization swelling cause and bony spur pressuring nerve to cause because of bony spur rapidly, eliminate and alleviate functional activity obstacle, the effect that also has obvious suppression and atrophy bony spur simultaneously.
2, the present invention adopts the external application dosage form, compare with other dosage form, pill, capsule, the electuary whole body absorbs, difficulty reaches the affected part deficiency had both been overcome, can reach the affected part rapidly though also overcome liquor preparation, but use the defective that is restricted owing to the ethanol stimulating intestine and stomach, compare with traditional plaster, overcome plaster again because of the breathability difference with directly be coated with the symptoms such as skin allergy that erosion skin causes, and outer liniment also have local action lastingly, not volatile advantage.Therefore, adopt the external application dosage form can give full play to the characteristics that medicine is easily absorbed by the affected part, play very big assosting effect for therapeutic effect.
3, show through how tame 258 routine clinical use results' course of treatment of hospital, produce effects 140 examples, effective 106 examples, total effective rate reaches 95.40%, and is especially better to the seriously limited patient's effect of sharp ache, functional activity.
4, to have zest little in the present invention, and permeability is strong, good permeability, characteristics easy to use, is suitable for local prolonged and repeated use, does not have any untoward reaction.
5, the present invention adopts the natural Chinese medicines material to make, and is without any side effects, safe and reliable, and manufacturing process is simple, and cost of manufacture is cheap, remarkable in economical benefits.
Below be embodiments of the invention:
Embodiment 1:
Form and prescription:
Rhizoma Drynariae 1.5kg, Olibanum 2kg, Myrrha 2kg, Radix Aconiti 1.5kg, Radix Aconiti Kusnezoffii 1.5kg, Rhizoma Arisaematis 2kg, Rhizoma Pinelliae 2kg, Rhizoma Et Radix Notopterygii 2kg, Radix Angelicae Pubescentis 2kg, Semen Sinapis Albae 1.25kg, Fructus Gleditsiae Abnormalis 1.25kg, Flos Carthami 1.25kg, Lignum Sappan 0.5kg, Herba Asari 0.25kg, Pericarpium Zanthoxyli 0.25kg, Herba speranskiae tuberculatae 0.75kg, Camphora 1.25kg, Borneolum Syntheticum 0.5kg, Colophonium 1.25kg.
Processing technology: earlier Camphora, Borneolum Syntheticum and Colophonium pulverize separately are also crossed 100 mesh sieves, sieve standby.All the other distinguish the flavor of respectively that Chinese medicine is picked respectively, the accurate weighing of ratio requirement according to dosage mixes and pulverizes and cross 60 mesh sieves after the cutting, camphorate in the screening, Borneolum Syntheticum and Colophonium and abundant mix homogeneously, and be dosage unit cloth collation package with 20g, the external plastic bag sealing is made.
Embodiment 2:
Form and prescription:
Rhizoma Drynariae 6kg, Olibanum 8kg, Myrrha 8kg, Radix Aconiti 4kg, Radix Aconiti Kusnezoffii 4kg, Rhizoma Arisaematis 8kg, Rhizoma Pinelliae 8kg, Rhizoma Et Radix Notopterygii 2kg, Radix Angelicae Pubescentis 2kg, Semen Sinapis Albae 3kg, Fructus Gleditsiae Abnormalis 5kg, Flos Carthami 5kg, Lignum Sappan 5kg, Herba Asari 4kg, Pericarpium Zanthoxyli 4kg, Herba speranskiae tuberculatae 6kg, Camphora 15kg, Borneolum Syntheticum 1kg, Colophonium 2kg.
Processing technology: with embodiment 1.
Embodiment 3:
Form and prescription:
Rhizoma Drynariae 20kg, Olibanum 25kg, Myrrha 25kg, Radix Aconiti 15kg, Radix Aconiti Kusnezoffii 10kg, Rhizoma Arisaematis 30kg, Rhizoma Pinelliae 30kg, Rhizoma Et Radix Notopterygii 40kg, Radix Angelicae Pubescentis 40kg, Semen Sinapis Albae 20kg, Fructus Gleditsiae Abnormalis 20kg, Flos Carthami 20kg, Lignum Sappan 25kg, Herba Asari 20kg, Pericarpium Zanthoxyli 20kg, Herba speranskiae tuberculatae 30kg, Camphora 75kg, Borneolum Syntheticum 10kg, Colophonium 25kg.
Processing technology: with embodiment 1.
Embodiment 4:
Form and prescription:
Rhizoma Drynariae 2.5kg, Olibanum 1.5kg, Myrrha 1.5kg, Radix Aconiti 1kg, Radix Aconiti Kusnezoffii 3kg, Rhizoma Arisaematis 2.5kg, Rhizoma Pinelliae 2.5kg, Rhizoma Et Radix Notopterygii 4kg, Radix Angelicae Pubescentis 4kg, Semen Sinapis Albae 1kg, Fructus Gleditsiae Abnormalis 1kg, Flos Carthami 1kg, Lignum Sappan 2.5kg, Herba Asari 2kg, Pericarpium Zanthoxyli 2kg, Herba speranskiae tuberculatae 3kg, Camphora 7.5kg, Borneolum Syntheticum 1kg, Colophonium 2.5kg gives birth to Radix Puerariae 4kg.
Processing technology: earlier Camphora, Borneolum Syntheticum and Colophonium pulverize separately are also crossed 120 mesh sieves, sieve standby.All the other distinguish the flavor of respectively that Chinese medicine is picked respectively, the accurate weighing of ratio requirement according to dosage mixes and pulverizes and cross 100 mesh sieves after the cutting, camphorate in the screening, Borneolum Syntheticum and Colophonium and abundant mix homogeneously, and be dosage unit cloth collation package with 15g, the external plastic bag sealing is made.Present embodiment is applicable to hyperosteogeny of cervical vertebra.
Embodiment 5:
Form and prescription:
Rhizoma Drynariae 1.5kg, Olibanum 2kg, Myrrha 2kg, Radix Aconiti 2.5kg, Radix Aconiti Kusnezoffii 2.5k, Rhizoma Arisaematis 2kg, Rhizoma Pinelliae 2kg, Rhizoma Et Radix Notopterygii 4kg, Radix Angelicae Pubescentis 4kg, Semen Sinapis Albae 2kg, Fructus Gleditsiae Abnormalis 2kg, Flos Carthami 2kg, Lignum Sappan 2.5kg, Herba Asari 2kg, Pericarpium Zanthoxyli 2kg, Herba speranskiae tuberculatae 3kg, Camphora 7.5kg, Borneolum Syntheticum 1kg, Colophonium 1.5kg gives birth to Radix Puerariae 2kg.
Processing technology: with embodiment 4.
Embodiment 6:
Form and prescription:
Rhizoma Drynariae 12kg, Olibanum 16kg, Myrrha 16kg, Radix Aconiti 10kg, Radix Aconiti Kusnezoffii 10kg, Rhizoma Arisaematis 14kg, Rhizoma Pinelliae 14kg, Rhizoma Et Radix Notopterygii 10kg, Radix Angelicae Pubescentis 10kg, Semen Sinapis Albae 8kg, Fructus Gleditsiae Abnormalis 6kg, Flos Carthami 6kg, Lignum Sappan 6kg, Herba Asari 6kg, Pericarpium Zanthoxyli 6kg, Herba speranskiae tuberculatae 10kg, Camphora 16kg, Borneolum Syntheticum 4kg, Colophonium 8kg gives birth to Radix Puerariae 12kg.
Processing technology: with example 4.
Embodiment 7:
Form and prescription:
Rhizoma Drynariae 1.5kg, Olibanum 2kg, Myrrha 2kg, Radix Aconiti 1.5kg, Radix Aconiti Kusnezoffii 1.5kg, Rhizoma Arisaematis 1.75kg, Rhizoma Pinelliae 1.75kg, Rhizoma Et Radix Notopterygii 1kg, Radix Angelicae Pubescentis 1kg, Semen Sinapis Albae 1kg, Fructus Gleditsiae Abnormalis 1kg, Flos Carthami 1kg, Lignum Sappan 1kg, Herba Asari 0.5kg, Pericarpium Zanthoxyli 0.5kg, Herba speranskiae tuberculatae 1kg, Camphora 1.5kg, Borneolum Syntheticum 0.5kg, Colophonium 1kg, Herba Epimedii 2kg.
Processing technology: earlier Camphora, Borneolum Syntheticum and Colophonium pulverize separately are also crossed 140 mesh sieves, sieve standby.All the other distinguish the flavor of respectively that Chinese medicine is picked respectively, the accurate weighing of ratio requirement according to dosage mixes and pulverizes and cross 80 mesh sieves after the cutting, camphorate in the screening, Borneolum Syntheticum and Colophonium and abundant mix homogeneously, and be dosage unit cloth collation package with 40g, the external plastic bag sealing is made.Present embodiment is applicable to lumbar vertebra hyperosteogeny.
Embodiment 8:
Form and prescription:
Rhizoma Drynariae 20kg, Olibanum 35kg, Myrrha 35kg, Radix Aconiti 25kg, Radix Aconiti Kusnezoffii 30kg, Rhizoma Arisaematis 30kg, Rhizoma Pinelliae 30kg, Rhizoma Et Radix Notopterygii 35kg, Radix Angelicae Pubescentis 30kg, Semen Sinapis Albae 15kg, Fructus Gleditsiae Abnormalis 25kg, Flos Carthami 20kg, Lignum Sappan 15kg, Herba Asari 15kg, Pericarpium Zanthoxyli 15kg, Herba speranskiae tuberculatae 25kg, Camphora 50kg, Borneolum Syntheticum 5kg, Colophonium 15kg, Herba Epimedii 30kg.
Processing technology: with embodiment 7.
Embodiment 9:
Form and prescription:
Rhizoma Drynariae 6kg, Olibanum 6kg, Myrrha 6kg, Radix Aconiti 4kg, Radix Aconiti Kusnezoffii 3kg, Rhizoma Arisaematis 5kg, Rhizoma Pinelliae 5kg, Rhizoma Et Radix Notopterygii 6kg, Radix Angelicae Pubescentis 7kg, Semen Sinapis Albae 5kg, Fructus Gleditsiae Abnormalis 3kg, Flos Carthami 5kg, Lignum Sappan 4kg, Herba Asari 3kg, Pericarpium Zanthoxyli 3kg, Herba speranskiae tuberculatae 5kg, Camphora 13kg, Borneolum Syntheticum 2kg, Colophonium 5kg, Herba Epimedii 4kg.
Processing technology: with embodiment 7.
Embodiment 10:
Form and prescription:
Rhizoma Drynariae 12kg, Olibanum 14kg, Myrrha 14kg, Radix Aconiti 12kg, Radix Aconiti Kusnezoffii 12kg, Rhizoma Arisaematis 14kg, Rhizoma Pinelliae 14kg, Rhizoma Et Radix Notopterygii 6kg, Radix Angelicae Pubescentis 6kg, Semen Sinapis Albae 10kg, Fructus Gleditsiae Abnormalis 8kg, Flos Carthami 6kg, Lignum Sappan 6kg, Herba Asari 4kg, Pericarpium Zanthoxyli 4kg, Herba speranskiae tuberculatae 8kg, Camphora 24kg, Borneolum Syntheticum 2kg, Colophonium 8kg, Radix Achyranthis Bidentatae 16kg.
Processing technology: earlier Camphora, Borneolum Syntheticum and Colophonium pulverize separately are also crossed 120 mesh sieves, sieve standby.All the other distinguish the flavor of respectively that Chinese medicine is picked respectively, the accurate weighing of ratio requirement according to dosage mixes and pulverizes and cross 90 mesh sieves after the cutting, camphorate in the screening, Borneolum Syntheticum and Colophonium and abundant mix homogeneously, and be dosage unit cloth collation package with 40g, the external plastic bag sealing is made.Present embodiment is applicable to knee joint hyperosteogeny.
Embodiment 11:
Form and prescription:
Rhizoma Drynariae 1.25kg, Olibanum 2kg, Myrrha 2kg, Radix Aconiti 1kg, Radix Aconiti Kusnezoffii 1kg, Rhizoma Arisaematis 2kg, Rhizoma Pinelliae 2kg, Rhizoma Et Radix Notopterygii 1.5kg, Radix Angelicae Pubescentis 1.5kg, Semen Sinapis Albae 0.75kg, Fructus Gleditsiae Abnormalis 1.25kg, Flos Carthami 0.5kg, Lignum Sappan 1kg, Herba Asari 1kg, Pericarpium Zanthoxyli 0.5kg, Herba speranskiae tuberculatae 1kg, Camphora 2.25kg, Borneolum Syntheticum 0.25kg, Colophonium 0.75kg, Radix Achyranthis Bidentatae 1.5kg.
Processing technology: with embodiment 10.
Embodiment 12:
Form and prescription:
Rhizoma Drynariae 12kg, Olibanum 12kg, Myrrha 12kg, Radix Aconiti 12kg, Radix Aconiti Kusnezoffii 12kg, Rhizoma Arisaematis 12kg, Rhizoma Pinelliae 12kg, Rhizoma Et Radix Notopterygii 12kg, Radix Angelicae Pubescentis 12kg, Semen Sinapis Albae 8kg, Fructus Gleditsiae Abnormalis 8kg, Flos Carthami 8kg, Lignum Sappan 8kg, Herba Asari 8kg, Pericarpium Zanthoxyli 8kg, Herba speranskiae tuberculatae 8kg, Camphora 20kg, Borneolum Syntheticum 2kg, Colophonium 6kg, Radix Achyranthis Bidentatae 8kg.
Processing technology: with embodiment 10.
Embodiment 13:
Form and prescription:
Rhizoma Drynariae 4kg, Olibanum 4kg, Myrrha 4kg, Radix Aconiti 5kg, Radix Aconiti Kusnezoffii 5kg, Rhizoma Arisaematis 5kg, Rhizoma Pinelliae 5kg, Rhizoma Et Radix Notopterygii 4kg, Radix Angelicae Pubescentis 4kg, Semen Sinapis Albae 5kg, Fructus Gleditsiae Abnormalis 5kg, Flos Carthami 5kg, Lignum Sappan 5kg, Herba Asari 4kg, Pericarpium Zanthoxyli 4kg, Herba speranskiae tuberculatae 5kg, Camphora 15kg, Borneolum Syntheticum 2kg, Colophonium 2kg, Radix Et Rhizoma Rhei 8kg.
Processing technology: earlier Camphora, Borneolum Syntheticum and Colophonium pulverize separately are also crossed 140 mesh sieves, sieve standby.All the other distinguish the flavor of respectively that Chinese medicine is picked respectively, the accurate weighing of ratio requirement according to dosage mixes and pulverizes and cross 100 mesh sieves after the cutting, camphorate in the screening, Borneolum Syntheticum and Colophonium and abundant mix homogeneously, and be dosage unit cloth collation package with 10g, the external plastic bag sealing is made.Present embodiment is applicable to calcaneus portion hyperosteogeny.
Embodiment 14:
Form and prescription:
Rhizoma Drynariae 2.5kg, Olibanum 4kg, Myrrha 4kg, Radix Aconiti 3kg, Radix Aconiti Kusnezoffii 3kg, Rhizoma Arisaematis 4kg, Rhizoma Pinelliae 4kg, Rhizoma Et Radix Notopterygii 4kg, Radix Angelicae Pubescentis 4kg, Semen Sinapis Albae 2kg, Fructus Gleditsiae Abnormalis 2kg, Flos Carthami 1kg, Lignum Sappan 1kg, Herba Asari 0.5kg, Pericarpium Zanthoxyli 0.5kg, Herba speranskiae tuberculatae 1.5kg, Camphora 3kg, Borneolum Syntheticum 1kg, Colophonium 2kg, big gold kg.
Processing technology: with embodiment 13.
Embodiment 15:
Form and prescription:
Rhizoma Drynariae 30kg, Olibanum 35kg, Myrrha 35kg, Radix Aconiti 30kg, Radix Aconiti Kusnezoffii 30kg, Rhizoma Arisaematis 40kg, Rhizoma Pinelliae 40kg, Rhizoma Et Radix Notopterygii 30kg, Radix Angelicae Pubescentis 30kg, Semen Sinapis Albae 10kg, Fructus Gleditsiae Abnormalis 10kg, Flos Carthami 20kg, Lignum Sappan 20kg, Herba Asari 10kg, Pericarpium Zanthoxyli 10kg, Herba speranskiae tuberculatae 30kg, Camphora 40kg, Borneolum Syntheticum 10kg, Colophonium 20kg, Radix Et Rhizoma Rhei 20kg.
Processing technology: with embodiment 13.
Claims (2)
1, a kind of dressing medicine for treating hyperosteogeny, it is characterized in that: externally dressing is made up of Rhizoma Drynariae, Olibanum, Myrrha, Radix Aconiti, Radix Aconiti Kusnezoffii, Rhizoma Arisaematis, Rhizoma Pinelliae, Rhizoma Et Radix Notopterygii, Radix Angelicae Pubescentis, Semen Sinapis Albae, Fructus Gleditsiae Abnormalis, Flos Carthami, Lignum Sappan, Herba Asari, Pericarpium Zanthoxyli, Herba speranskiae tuberculatae, Camphora, Borneolum Syntheticum and Colophonium, and its concrete percentage by weight is:
Rhizoma Drynariae 3-6% Olibanum 3-8%
Myrrha 3-8% Radix Aconiti 2-6%
Radix Aconiti Kusnezoffii 2-6% Rhizoma Arisaematis 4-8%
Rhizoma Pinelliae 4-8% Rhizoma Et Radix Notopterygii 2-8%
Radix Angelicae Pubescentis 2-8% Semen Sinapis Albae 2-5%
Fructus Gleditsiae Abnormalis 2-5% Flos Carthami 2-5%
Lignum Sappan 2-5% Herba Asari 1-4%
Pericarpium Zanthoxyli 1-4% Herba speranskiae tuberculatae 2-6%
Camphora 5-15% Borneolum Syntheticum 1-2%
Colophonium 2-5%.
2, make the method for the described dressing medicine for treating hyperosteogeny of claim 1, it is characterized in that: earlier with Camphora, Borneolum Syntheticum and Colophonium pulverize separately, and cross the 100-140 mesh sieve respectively, all the other are respectively distinguished the flavor of after Chinese medicines ratio requirement mixing according to dosage, pulverize and cross the 60-100 mesh sieve together, add Camphora, Borneolum Syntheticum and Colophonium and the abundant mix homogeneously of aequum in the screening, get doses and pack with cloth, the external plastic bag sealing is made.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94103521A CN1049586C (en) | 1994-04-20 | 1994-04-20 | Dressing medicine for treating hyperosteogeny and the prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN94103521A CN1049586C (en) | 1994-04-20 | 1994-04-20 | Dressing medicine for treating hyperosteogeny and the prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1103796A CN1103796A (en) | 1995-06-21 |
| CN1049586C true CN1049586C (en) | 2000-02-23 |
Family
ID=5031129
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN94103521A Expired - Fee Related CN1049586C (en) | 1994-04-20 | 1994-04-20 | Dressing medicine for treating hyperosteogeny and the prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1049586C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1299709C (en) * | 2004-03-01 | 2007-02-14 | 邓国荣 | Chinese medicne plaster for bone injury and its preparation method |
| CN101167818B (en) * | 2006-10-26 | 2011-01-19 | 杨书楼 | Hyperosteogeny plaster |
| CN102743732B (en) * | 2012-07-16 | 2013-07-03 | 张家港市维康盲人推拿按摩保健中心 | Chinese medicine damp-hot compress bag for treating hyperosteogeny |
| CN106138539A (en) * | 2016-08-16 | 2016-11-23 | 孙振成 | Chinese medicine preparation of a kind of promoting blood circulation to remove obstruction in the collateral and preparation method thereof and usage |
| CN108310158B (en) * | 2018-04-17 | 2021-02-09 | 徐永淦 | A topical Chinese medicinal composition and its preparation method |
| CN110141624A (en) * | 2019-06-17 | 2019-08-20 | 贺哲 | A kind of anti-bone regeneration patch and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1063044A (en) * | 1992-01-18 | 1992-07-29 | 刘湘生 | The production method of " tong " Astragalus membranaceus spur-subsidence pill |
-
1994
- 1994-04-20 CN CN94103521A patent/CN1049586C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1063044A (en) * | 1992-01-18 | 1992-07-29 | 刘湘生 | The production method of " tong " Astragalus membranaceus spur-subsidence pill |
Non-Patent Citations (7)
| Title |
|---|
| 《中药大辞典》第一版 1986.5.1 江苏新医学院，上海科学技术出版社 * |
| 《中药大辞典》第一版 1986.5.1 江苏新医学院，上海科学技术出版社;北京中医1990,(5) 1990.5.31 方海东，骨刺膏外敷治疗骨质增生72例疗效观察;广西中医药1993,16(4) 1993.4.30 李华春等，骨刺散外敷治疗腰椎骨质增生症78例;新中医1989,21(11) 1989.11.30 赵向阳，中药热敷法治疗骨质增生;中西医结合杂志1989,9(7) 1989.7.31 姬长生，骨刺膏敷治疗骨质增生460例报告;中药通报1987,12(11) 1987.11.30 李玉岩等，应用骨刺膏治疗骨质增生症66例 * |
| 中药通报1987,12(11) 1987.11.30 李玉岩等，应用骨刺膏治疗骨质增生症66例 * |
| 中西医结合杂志1989,9(7) 1989.7.31 姬长生，骨刺膏敷治疗骨质增生460例报告 * |
| 北京中医1990,(5) 1990.5.31 方海东，骨刺膏外敷治疗骨质增生72例疗效观察 * |
| 广西中医药1993,16(4) 1993.4.30 李华春等，骨刺散外敷治疗腰椎骨质增生症78例 * |
| 新中医1989,21(11) 1989.11.30 赵向阳，中药热敷法治疗骨质增生 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1103796A (en) | 1995-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1061854C (en) | Medicinal preparation for treatment and prevention of gynopathy | |
| CN1857541A (en) | Plaster for treating rheumatism and osteoarthrosis | |
| CN1095674C (en) | Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease | |
| CN101816736B (en) | Chinese medicament capsule for curing nasosinusitis | |
| CN1047090C (en) | Plaster for curing cough with dyspnea | |
| CN1049586C (en) | Dressing medicine for treating hyperosteogeny and the prepn. method | |
| CN1283309C (en) | Pure medicinal liquor | |
| CN1861155A (en) | Method for preparing traditional Chinese medicine for treating rheumatism and rheumatoid disease, and said medicine thereby | |
| CN102526482A (en) | Traditional Chinese medicine preparation for treating lumbar disc herniation | |
| CN102397528B (en) | Compound propolis composition for treating chicken infectious anemia and preparation method thereof | |
| CN1095287A (en) | Abdominal protecting medicine for external use | |
| CN1051471C (en) | Drug composition for curing osteoporosis | |
| CN1186028C (en) | Antagesic Chinese medicine and its preparing process and usage | |
| CN1438028A (en) | Plaster for treating lumbar vertebra osteoproliferation | |
| CN1259933C (en) | Chinese medicinal composition for treating coronary disease and its preparation and application | |
| CN1160102C (en) | Chinese medicine for curing female chronic inflammation | |
| CN1241598C (en) | Chinese medicine for treating periodontal disease and its preparing process and application | |
| CN1091295A (en) | The migrainous Chinese medicine of a kind of treatment | |
| CN1290551C (en) | A Chinese medicinal composition for invigorating kidney and strengthening bone | |
| CN102631553A (en) | Medicament for treating reflux esophagitis | |
| CN1225266C (en) | Medicine for curing wind dampness, injuries from falls and ulcer in opening of sore | |
| CN1698808A (en) | Chinese medicinal composition for treating ulcer | |
| CN106236899A (en) | A kind of Chinese medicine composition of anemofrigid-damp arthralgia | |
| CN100406033C (en) | Medicated bag for curing spur disease | |
| CN1340350A (en) | Chewing medicine for treating facial paralysis and its preparing process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |